Nidal Alkurdy
Neurology · Mankato, MNNPI 1548362114
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (38.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Kyowa Kirin, Inc. at 48.9% of the total. Among neurology clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 89 payments — averaging $177.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kyowa Kirin, Inc.$8K
- Lundbeck LLC$6K
- Catalyst Pharmaceuticals, Inc.$2K
- AbbVie$94
- Novartis$68
- Bristol Myers Squibb$67
- plus $771 from 29 others
What the payments were for
- Consulting fees$6,16039%
- Speaking & faculty fees$5,76136%
- Travel & lodging$2,45315%
- Food & beverage$1,4539%
- Education$130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kyowa Kirin, Inc. | 12 | $7,740 |
| Lundbeck LLC | 11 | $5,535 |
| Catalyst Pharmaceuticals, Inc. | 4 | $1,565 |
| AbbVie(2 entities) | 7 | $94 |
| Novartis | 5 | $68 |
| Bristol Myers Squibb | 3 | $67 |
| Tanabe Pharma America, Inc. | 4 | $63 |
| Upsher-smith Laboratories LLC | 2 | $60 |
| Eisai Inc. | 2 | $50 |
| Biogen | 3 | $49 |
| Biohaven Pharmaceuticals, Inc. | 3 | $47 |
| Acadia Pharmaceuticals Inc | 3 | $47 |
| Adamas Pharmaceuticals, Inc. | 2 | $33 |
| Boston Scientific | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 2 | $30 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Merz North America, Inc. | 2 | $28 |
| EMD Serono, Inc. | 2 | $25 |
| Livanova USA, Inc. | 1 | $25 |
| Harmony Biosciences LLC | 1 | $23 |
| Lilly USA, LLC | 2 | $23 |
| Impel Pharmaceuticals Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $17 |
| Corium, LLC | 1 | $16 |
| Greenwich Biosciences, Inc. | 1 | $16 |
| Philips North America LLC | 1 | $16 |
| Advanced Respiratory, Inc | 1 | $16 |
| Grifols USA, LLC | 1 | $15 |
| Sunovion Pharmaceuticals Inc. | 1 | $14 |
| Sanofi | 1 | $14 |
| MDD US Operations, LLC | 1 | $14 |
| Itamar Medical Inc | 1 | $14 |
| SK Life Science, Inc. | 1 | $12 |
| Acorda Therapeutics, Inc | 1 | $11 |
| AstraZeneca | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,840 in reported general payments places this provider in the 90th percentile of 434 neurology providers in Minnesota.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 46 | $1,048 |
| Memantine Hcl ErMemantine Hcl | 12 | $931 |
| Donepezil Hcl | 49 | $446 |
| Ropinirole Hcl | 20 | $423 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 17 | $412 |
| Levetiracetam | 13 | $383 |
Paid to pharmacies, not to this prescriber.
Other neurology in Mankato
- Lisa DavidsonMankato$113K
- Jeffery AllenMinneapolis$1.1M
- Jonathan CalkwoodGolden Valley$493K
- Alejandro RabinsteinRochester$305K
- Patricia PenovichSaint Paul$304K
- Sean PittockRochester$231K
- Irfan AltafullahGolden Valley$203K
- Jessica StulcGolden Valley$199K
- Akram DastagirGolden Valley$174K
- Jessica HeiringGolden Valley$149K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.